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The chemical composition and biological activity of a sample of yellow propolis fromMato Grosso do Sul, Brazil (EEP-YMS), were
investigated for the first time and compared with green, brown, and red types of Brazilian propolis and with a sample of yellow
propolis from Cuba. Overall, EEP-Y MS had different qualitative chemical profiles, as well as different cytotoxic and antimicrobial
activities when compared to the other types of propolis assessed in this study and it is a different chemotype of Brazilian propolis.
Absence of phenolic compounds and the presence of mixtures of aliphatic compounds in yellow propolis were determined by
analysing 1H-NMR spectra and fifteen terpenes were identified by GC-MS. EEP-Y MS showed cytotoxic activity against human
tumour strain OVCAR-8 but was not active against Gram-negative or Gram-positive bacteria. Our results confirm the difficulty
of establishing a uniform quality standard for propolis from diverse geographical origins. The most appropriate pharmacological
applications of yellow types of propolis must be further investigated.
1. Introduction
Propolis is a beehive product popularly used to treat or
prevent several disorders such as wound infections and
respiratory conditions [1]. The regular intake of propolis
has been indicated in traditional medicine as a way to
promote health and enhance human resistance to infections
or malignant affections with no unwanted side effects.
Brazilian propolis was previously classified by Park et
al. [2] who described twelve distinct groups of Brazilian
propolis. Green propolis (type 12) from south-eastern Brazil
is currently the most exported Brazilian propolis. Green
propolis is rich in artepillin C and other prenylated phenolic
compounds with potent antitumour properties [3]. A brown
type of propolis is found in the southern regions of Brazil
(states of Parana´ and Santa Catarina) [1, 4]. Yellow propolis
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 6057650, 11 pages
http://dx.doi.org/10.1155/2016/6057650
2 Evidence-Based Complementary and Alternative Medicine
samples from northeast and south Brazil were found by Park
et al. [5] and classified in group 1 from southern region
and groups 9 and 11 from northeast. In addition, yellow
propolis from Cuba was described by Cuesta-Rubio et al.
[6]. A 13th type of Brazilian propolis was later identified as
the red propolis from northeastern Brazil [7]. Trusheva et
al. [8] showed that this red propolis was rich in phenolics,
triterpenoids, isoflavonoids, and prenylated benzophenones
and a naphthoquinone epoxide was isolated for the first time
from a natural source. Since then, red Brazilian propolis has
been the target of further investigation by several research
groups [6, 7, 9–13]. Sawaya et al. [4] have also carried out
several studies seeking to classify the Brazilian propolis based
on their ESI-MS fingerprints and chemometric multivariate
analysis.
Despite the great number of studies about Brazilian
propolis, the chemical composition of propolis from the
central-western region of Brazil has been scarcely inves-
tigated [4, 19]. Neither the chemical composition nor the
pharmacological properties of yellow Brazilian propolis have
been described so far. In the current study, we investigated
the chemical composition and cytotoxic and antimicrobial
activities of a sample of yellow Brazilian propolis collected
in the Pantanal ecosystem in Mato Grosso do Sul, Brazil.
Moreover, four samples of typical Brazilian classes of propo-
lis, green propolis from Sa˜o Paulo (EEP-G SP), green propolis
from Minas Gerais (EEP-G MG), red propolis from Bahia
(EEP-R BA), brown propolis from Parana´ (EEP-B PR), and
a sample of yellow propolis from Cuba (EMP-Y Cuba), were
included in the study, permitting the direct comparison with
the chemical characteristics and pharmacological potency of
yellow propolis.
2. Experimental
2.1. Propolis Samples and Extracts. Propolis was supplied
by beekeepers from different states of Brazil: red propolis
(Bahia), green propolis (Sa˜o Paulo), yellow propolis (Mato
Grosso do Sul), and brown propolis (Parana´). A sample of
green propolis from the state of Minas Gerais was purchased
in a local market. A sample of yellow propolis from Cuba
was prepared as a methanol extract. All propolis samples
were stored at −18∘C until extraction. Ethanol extracts of
propolis (EEP) were prepared using 10 g of each propolis
samples mixed with 100mL of absolute ethanol. The mixture
was stirred for one day under controlled speed (160 rpm) at
room temperature and then filtered.The filtrates were kept in
freezer overnight (temperature of −18∘C) and filtered again
to remove waxes. Solvent from the extractive solutions was
removed in a rotatory evaporator at 50∘C to obtain the dry
ethanol extracts of propolis (EEPs).
2.2. 1H-NMR Analysis. Samples of EEPs for 1H-NMR anal-
ysis were prepared as follow: a mixture of 100 𝜇L D
2
O (buffer
phosphate pH 7.04) and 600 𝜇L CD
3
OD was added to 30mg
of propolis extracts and sonicated for 15min.Themixturewas
centrifuged at 13000 rpm for 20min at room temperature.
The supernatant (600𝜇L) was transferred into an NMR
tube of 5mm. Sodium-3-trimethylsilyl-2,2,3,3-d
4
propionate
(TMSP 0.324mg/mL) was used as internal reference. All
NMR experiments were recorded at 298K in a Bruker
UltraShielding Plus 600MHz spectrometer operating at
14.6 T, equipped with a TCI cryoprobe for H-C/N-D. 1H
NMR spectra were acquired using a noesy pulse sequence
for presaturation on water resonance and spoil gradient
during mixing time (noesygppr1d, Bruker terminology). The
parameters set in this sequence were 4.0 s for relaxation delay
time, acquisition time of 3.99, data points of 140k, mixing
time of 10ms, and 128 scans with a spectral window of
30 ppm. Spectra were processed by applying an exponential
line broadening LB of 0.3 and manually phased trough
Topspin 3.0 (Bruker Biospin).
2.3. UPLC-ESI(−)-MS/MS. The EEPs were analysed on a
UPLC Acquity Chromatographer (Waters, Milford, USA)
coupled with a TQD Mass Spectrometer (Micromass-Waters
Manchester, England), with an Electrospray source (ESI).
Fingerprints were obtained by direct injection of 5 𝜇L of
extracts by flow infusion into the ESI source. Chromato-
graphic separation was carried out in a C
18
BEH Waters
Acquity analytical column (50mm × 2.1mm i.d., 1.7 𝜇m
particle size) held at 30∘C. A linear gradient elution was
carried outwithmili-Q purifiedwater containing 0.1% formic
acid (solvent A) and acetonitrile (solvent B) at a flow rate
of 0.2mL/min. Elution started with 95% of solvent A and
5% of solvent B. A linear gradient was performed until 100%
of solvent B in 9min and this condition was held for 1min.
Afterwards, the initial elution condition was reestablished in
2min, totalizing 12min for the chromatographic run. ESI(−)-
MS and tandem ESI(−)-MS/MS were obtained under the
following analytical conditions: capillary −3.5 kV, cone −30V,
source, and desolvation temperature were 150 and 350∘C,
respectively. For ESI(−)MS/MS, the energy for the collision
induced dissociations (CID) was 25V. Data were acquired
in the m/z 100–700 range. Diagnostic ions in the different
propolis samples were identified by the comparison of their
ESI(−)MS/MS dissociation patterns with authentic analytical
standards and/or by comparison with fragmentation pattern
from the literature.
2.4. GC-EIMS. An aliquot of dry yellow propolis extracts was
dissolved in ethyl acetate at a concentration of 500𝜇g/mL.
Volume samples of 1 𝜇L were injected in the splitless mode
into an AGILENT gas chromatograph (model 7890A GC
System), coupled with a mass spectrometer operating in EI
mode at 70 eV. A 5% phenyl 95% dimethylpolysiloxane cap-
illary column (30m × 0.25mm i.d., 0.25 𝜇m film thickness)
was held at 250∘C for 1min and then heated to 300∘C at
the rate of 5∘C/min. The final temperature was maintained
for 10min. Helium was used as the carrier gas. Injector
and detector temperature was 230∘C and 150∘C, respectively.
Compounds were identified by searching against a database
of mass spectra (NIST 2011 Mass Spectral Library, Agilent
Technologies).
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2.5. Cytotoxicity Assays. The cytotoxicity of propolis extracts
was evaluated against four human tumour cell lines: OVCAR-
8 (ovary carcinoma),HCT-116 (colorectal carcinoma), SF-295
(human glioblastoma), and LH-60 (promyelocytic leukemia)
obtained from the National Cancer Institute (Bethesda, MD,
USA). The general viability of cultured cells was deter-
mined by the reduction of the yellow dye 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to a
blue formazan product, as previously described byMosmann
[20]. The tumour cells were maintained in RPMI 1640
medium, supplemented with 10% foetal bovine serum, 1%
penicillin, and streptomycin at 37∘C with 5% CO
2
. For
all experiments, cells were seeded at 0.1 × 106 cells/mL
(LH-60, OVCAR-8, and SF-295) and 0.7 × 105 cells/mL
(HCT-116) and incubated during 72 h with propolis extracts
at 37∘C with 5% CO
2
. After centrifugation and solution
removing, MTT solution was added and the plates were
incubated and centrifuged and the solids dissolved in pure
and sterile DMSO. The absorbance was measured in a plate
spectrophotometer DTX-800 (Beckman Coulter) at 595 nm.
Investigation of the survival viability for nontumour cell line
L929 (mouse fibroblast)was also carried out.DMSO (solvent)
and doxorubicin (reference standard drug) were used as
negative and positive controls, respectively.
2.6. Antibacterial Activity. Antibacterial activity was eval-
uated against the following standard strains: (i) Gram-
positive bacteria: Staphylococcus aureus (ATCC 6538) and
Enterococcus faecalis (ATCC 29212) (ii) bacteria Gram-
negative: Pseudomonas aeruginosa (ATCC 25853) and
Escherichia coli (ATCC 8739). All samples were obtained
from INCQS/FIOCRUZ (National Institute of Quality
Control in Health, Brazil). Furthermore, one clinic isolate,
methicillin-resistant Staphylococcus aureus (MRSA), was also
applied as test organism and obtained from cultures of patient
samples existing in the Public Hospital (Bacteriological
Laboratory) of Bele´m city, Para´, Brazil.
All bacteria were previously seeded in Petri plates
containing Mueller Hinton agar (Merck, Germany) and
incubated at 35∘C for 24 hours. For bacterial inoculum
preparation, strains were grown to exponential phase in
Mueller Hinton broth (Merck, Germany) at 37∘C for 24 h
and adjusted by diluting fresh cultures to turbidity equivalent
to 0.5 McFarland scale (approximately 2 × 108 CFU/mL)
and then diluted until 1 × 103 CFU/mL, as described by
Clinical and Laboratory Standards Institute [21]. Minimum
inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) assays were performed using the broth
microdilution method in MHB [21]. MIC is defined as the
lowest concentration of extract with no visible growth of
the microorganism in the resazurin colorimetric assay. To
determine MIC, propolis extracts were dissolved in DMSO
at the highest concentration (19000𝜇g/mL) to be tested. A
serial twofold dilution was made in a concentration range
from 100 to 19000𝜇g/mL in 1mL sterile test tubes containing
MHB. For the microdilution test, the inoculum (100 𝜇L)
containing 5 × 103 CFU/mL was added to each well and
100 𝜇L was transferred into consecutive wells. After 24 h of
incubation, 15𝜇L of resazurin (1 𝜇g/mL), which wasmetabol-
ically reduced by active cells to a colour derivative, was added
to the wells to allow visual identification of metabolic activity
[22]. After incubation, the development of a purple-pink
colour was considered as the indicative of bacterial growth.
Therefore, MIC was read as the lowest concentration of the
extract where the purple-pink colour was not observed. To
determine MBC, 10 𝜇L of broth was taken from each well
and incubated in Mueller Hinton agar at 37∘C for 24 h and
for each bacterium. The MBC was defined as the lowest
extract concentration that resulted in a colony count lower
than three colonies per mL (99.9% killing) or no bacterial
growth, as described by de Quadros et al. [23]. Each test
was performed in three replicates. Negative control consisted
of 100𝜇L of the bacterial inoculum and 100 𝜇L of DMSO.
Chloramphenicol (50 𝜇g/mL) and gentamicin (10 𝜇g/mL)
were used as positive controls for Gram-positive and Gram-
negative bacteria, respectively.
2.7. Statistical Analysis. For chemometrics analysis of NMR
a bucket table was created using AMIX Statistics software
(version 3.9.7, Bruker Biospin). A bucket window of 0.04 ppm
was choosen for spectral binning and residual water sig-
nal (4.90–5.00 ppm) and methanol (3.29–3.33 ppm) were
excluded together with noise regions prior bucketing process.
Principal component analysis (PCA) was used in order to
compare the qualitative chemical composition of the diferent
types of propolis extracts from several states of Brazil.
Statistical differences between experimental types of propolis
were verified by ANOVA followed by Fisher and Tukey test at
95% significance (𝑝 < 0.05).
3. Results and Discussion
3.1. Qualitative Comparison of the Chemical Composition of
Propolis Extracts by 1H NMR, ESI(−)-MS, and LC-ESI(−)-
MS/MS. The qualitative profile of green, red, brown, and
yellow propolis from different regions of Brazil and one
yellow propolis from Cuba was evaluated first by 1H NMR
(Figure 1) and by ESI(−)-MS fingerprinting (Figure 2). The
samples of Brazilian propolis showed clearly distinct 1HNMR
(Figure 1) and ESI(−)-MS (Figure 2) patterns, indicating
different chemical composition. The most striking feature
in the 1H NMR spectrum of yellow propolis is the absence
of signals from aromatic compounds and the most down
field hydrogens are vinyl hydrogens at 𝛿 5.0 to 6.0 ppm. This
indicates the lack of abundance of phenolics compounds that
are typically present in the green, brown, and red types of
Brazilian propolis. In Figure 1, solvent signal (D
2
O/CD
3
OD)
at 3.36–3.27 ppm and the signal for the internal reference
TMSP were excluded from NMR spectra for better graphic
quality.
Through 1H-NMR technique, it is possible to verify the
chemical class of only the most abundant compounds in
the extracts, once NMR technique is quite susceptible to
compound concentration. Chemometric analysis of 1HNMR
data clustered propolis samples into three groups (Figure 3):
a group comprising the green propolis; a second group for
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Figure 1: 1HNMR (600MHz, CD
3
OD/D
2
O) of propolis extracts (solvent signal at 𝛿 3.36–3.27 and the signal for the internal reference TMSP
were excluded from NMR spectra).
the brown and red propolis; and a third group for the
yellow propolis. The Cuban and Brazilian yellow propolis
were grouped due to the predominance of resonances at 𝛿
0.7–1.1 ppm and 𝛿 1.23–1.32 ppm characteristic of hydrogens
bonded to Csp3 in aliphatic compounds.
The six samples of propolis were also analysed by
UPLC-ESI(−)-MS/MS to tentatively identify some of the
ions observed by ESI(−)-MS fingerprinting (Figure 2). A
total of twenty-nine known compounds were identified in
green, red and brown Brazilian propolis and Cuban yellow
propolis (Table 1). All these compounds have been previously
identified in propolis and correspond to phenolic com-
pounds, such as derivatives of benzoic and cinnamic acids,
flavonoids and prenylated phenolic compounds, but labdanic
terpenes were also found [3, 4].
3.2. Chemical Composition of Yellow Brazilian Propolis by GC-
EIMS. The lipophilic nature of the constituents in yellow
propolis made GC-MS the most suitable analytical technique
to analyse the chemical composition of this type of propolis.
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Figure 2: ESI(−)-MS fingerprints of propolis extracts.
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Figure 3: Principal component analysis of 1H-NMR data for extracts of propolis.
A total of fifteen triterpenoids were tentatively identified in
the extract of yellow propolis (Figure 4) through comparison
of their fragmentation profile with data from theNIST library
and the literature data. At least three triterpenoids were
already reported for Brazilian type 6 propolis (red colour),
such as 𝛽-amyrin, lupeol, and olean-12-en-3-one [8, 18, 24].
A study of the chemical composition of propolis pro-
duced in the state of Piauı´ (Brazil) resulted in the iden-
tification of six triterpenoids derived from cycloartane:
isomangiferolic acid, mangiferolic acid, mangiferonic acid,
ambonic acid, ambolic acid, and 24-methylene cycloartane-
3𝛽,26-diol. The authors mentioned that these compounds
were previously isolated from the stem bark of species of
Mangifera indica (Anacardiaceae) and suggested that this
species could be the source of propolis fromPiauı´. Pentacyclic
triterpenoids, such as lupeol, 𝛼-amyrin and 𝛽-amyrin, and
tetracyclic cycloartenol type, have shown significant anti-
inflammatory activity [25].
Herna´ndez et al. [26] reported a quali-quantitative GC-
MS study of 19 samples of yellow Cuban propolis. Yellow
Cuban propolis comprised two major groups: type A, rich in
triterpenic alcohols and with the presence of polymethoxy-
lated flavonoids asminor constituents, and type B, containing
acetyl triterpenes as the main constituents [6]. Through GC-
MS compounds of low polarity were identified such as lanos-
terol,𝛽-amyrone,𝛽-amyrin, germanicol, lupeol, cycloartenol,
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Table 1: Propolis constituents identified by UPLC-ESI(−)-MS/MS.
𝑚/𝑧
[M-H]− Compound Propolis origin
ESI(−)-MS/MS
𝑚/𝑧 (relative intensity%) Reference
151 SP 150 (100); 147 (65); 127 (10); 121 (15)
163 p-Coumaric acid SP, Cuba, MG, PR 163 (20); 119 (100) a, [4, 14, 15]
179 Caffeic acid SP, MG, PR 179 (40); 135 (100); 116 (50) [14]
229 2,2-Dimethyl-6-carboxyethenyl-2H-1-benzopyrane SP, MG 185 (100); 168.9 (50); 146 (20) a, [4]
231 4-Hydroxy-3-prenylcinnamicacid SP, MG, PR 231 (15); 187 (30); 132 (100) a, [4, 15, 16]
233 Viscidone SP, MG, PR 233 (25); 188 (100); 133 (50); 132 (85) a
247 3,4-Dihydroxy-5-prenylcinnamicacid SP, MG, PR 247 (40); 203 (60); 148 (100) a, [16]
253 2-Hydroxy-4-methoxychalcone BA 253 (80); 237 (95); 209 (100); 161 (70); 136 (92) [17]
253 SP, MG 220 (5); 162 (20), 145 (30); 118 (100)
255 Liquiritigenin BA 255 (35); 135 (40); 119 (100) [7, 9, 17, 18]
255 BA, Cuba 255 (45); 135 (35); 119 (100)
255 MS 254 (52); 209 (100); 191 (50); 153 (62); 123 (62);109 (61)
285 (3S)-Vestitone BA, MG 285 (25); 269 (33); 147 (18); 109 (100) [18]
285 Pinobanksin-5-methyl-ether SP, MG 285 (100); 252 (30); 163 (45); 151 (35); 136 (50) [14]
285 Kaempferol Cuba, BA 285 (83); 149 (100); 122 (85) [14]
297 BA 267 (85); 205 (100)
299 BA 299 (40); 284 (100)
299 Luteolin-methyl-ether BA 299 (40); 284 (100); 255 (25); 227 (30) [14, 15]
299 Kaempferide SP, Cuba, PR 299 (100); 284 (90); 200 (30); 151 (23) [15, 16]
299 Artepillin C SP, MG, PR 299 (90); 255 (100); 200 (97) a, [4, 16]
301 Dihydrokaempferide BA, SP, Cuba, MG, PR 301 (100); 283 (5); 152 (30) a, [16]
315 (3S)-Violanone BA 315 (20); 108 (100) [18]
315 Quercetin-3-methyl-ether BA 315 (80); 300 (55); 271 (50); 243 (100); 165 (48) a, [14]
315 Isorhamnetin SP, MG, PR 315 (100); 284 (20); 252 (30) a, [15]
315
(3-4-Hydroxy-3-methyl-2-
butenyl-4-hydroxy-5-prenyl)
cinnamic acid
SP, MG 315 (100); 253 (90); 241 (88); 198 (98) a
315
3-Hydroxy-2,2-dimethyl-8-
prenylchromane-6-propenoic
acid
SP, MG 315 (75); 271 (25); 253 (20); 244 (85); 198 (100);146 (45) [15]
317 BA 317 (20); 270 (23); 166 (48); 109 (100)
317 SP, MG 317 (25); 314 (50); 241 (100); 124 (73)
317 SP, MG 317 (10); 242 (40); 200 (100)
317 SP 317 (45); 273 (55); 160 (100)
317 MG 317 (40); 312 (100); 253 (50); 147 (80)
319 BA, PR 301 (100); 193 (25)
319 MS 319 (20); 223 (100);
329 BA 329 (30); 314 (55); 299 (100); 285 (35); 271 (100);182 (60)
329 Quercetin-dimethyl-ether SP, Cuba, MG, PR 229 (100); 314 (70); 299 (42); 270 (80); 227 (25) [14]
329 Betuletol SP, MG 329 (85); 314 (45); 299 (100); 270 (85); 257 (90)198 (50); 160 (35) a
333 Agathic acid SP, MG, PR 333 (45); 314 (40); 257 (30); 245 (35) a
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Table 1: Continued.
𝑚/𝑧
[M-H]− Compound Propolis origin
ESI(−)-MS/MS
𝑚/𝑧 (relative intensity%) Reference
347 Agathic acid 15-methyl ester SP 247 (70); 259 (20); 187 (100); 163 (60); 146 (80) a
353 Cuba, MS 353 (40); 335 (45); 151 (40); 112 (50)
361 15-Acetoxy cupressic acid MG, SP 361 (100); 317 (70); 242 (75); 159 (45); 126 (72) a
363
3-Prenyl-4-
dihydrocinnamoyloxy cinnamic
acid
SP, MG 363 (20); 187 (80); 149 (100) a, [15]
447
(E)-3-{-4-hydroxy-3-[(E)-4-(2,3-
dihydrocinnamoyl
oxy)-3-methyl-2-butenyl]-5-
prenylphenyl}-2-propenoic
acid
SP, MG, PR 447 (10); 297 (50); 197 (15); 149 (100) a, [16]
515 3,5-di-O-caffeoylquinic acid SP, MG, PR 515 (25); 353 (100); 173 (30) a, [4, 15]
aIdentification based on comparison with authentic analytical standards.
𝛽-amyrin acetate, 24-methylene-9,19-ciclolanostan-3𝛽-ol, 𝛼-
amyrin acetate, and lupeol acetate [26]. In our current report,
all these compounds were found in the sample of yellow
propolis from Pantanal (Mato Grosso do Sul, Brazil) demon-
strating a similar chemical profile for the Cuban andBrazilian
yellow propolis samples, which consequently formed a group
in PCA (Figure 3).
3.3. In Vitro Cytotoxicity Assays. In preliminary screening
of cytotoxic activity, the percentage of inhibition on three
tumour cell lines wasmeasured for each type of propolis (data
not shown). Green samples (EEP-G SP and EEP-G MG) had
low inhibition of all studied tumour cell lines, presenting low
cytotoxic potential. Brown (EEP-B PR) and red (EEP-R BA)
propolis had the highest cytotoxic potential with inhibition
percentages greater than 75% in at least two tumour cell
lines. Yellow propolis from Brazil (EEP-Y MS) showed high
cytotoxic activity only against OVCAR-8 tumour cell, thus
showing greater specificity against ovarian carcinoma.
Only extracts of red, brown, and yellow propolis, which
showed inhibition percentages above 75% in at least one
tumour cell, were considered for further experiments. An
analytical curve obtained by linear regression, varying the
concentration of extract of propolis and measuring inhi-
bition of cell proliferation, enabled the calculation of the
concentration required for each extract to inhibit 50%
(IC
50
) of tumour cells OVCAR-8 (ovary carcinoma), HCT-
116 (colorectal carcinoma), SF-295 (human glioblastoma),
and LH-60 (promyelocytic leukemia) (Table 2). The highest
concentration tested for each extract was 100𝜇g/mL.
According to criteria established by the National Cancer
Institute (NCI, USA), the IC
50
threshold for extracts with
promising cytotoxic activity value is 30𝜇g/mL. The results
showed that yellow propolis contains substances with cyto-
toxic effects. Brown propolis was effective against the four
cell lines studied. To evaluate the degree of selectivity against
tumour cell lines, IC
50
was also investigated against the non-
tumour cell line L929 (mouse fibroblast) and a selective index
(SI) was calculated as IC
50
(nontumour cell)/IC
50
(tumour
cell). The highest selectivity against all tumour cells was
shown by red propolis especially against LH-60 (leukemia
promyelocytic). da Silva Frozza et al. [17] also found that red
propolis had selective cytotoxic activity for tumour cell lines.
Yellow propolis had selective indexes between 0.91 and 1.84;
however, only values of SI ≥ 2 are considered significant [27].
Therefore, our results suggest that brown and red propolis
and, to a lesser extent, yellow propolis may act in a selective
way against tumour cells and show potential antitumour
activity. We previously demonstrated that propolis extracts
showed an in vivo antitumour activity in the experimental
model Sarcoma 180 tumour cells withmoderate toxicity effect
at experimental exposure levels when compared to 5-FU [16].
Propolis has been a subject of intensive research, especially in
the area of cancer, and its selectivity in vivo against tumours
must be further investigated.
3.4. Antibacterial Activity. Samples of green (EEP-GMG and
EEP-G SP) and red propolis (EEP-R BA) had high antibacte-
rial activity against Gram-positive bacteria, mainly S. aureus
(Table 3). Particularly, EEP-G SP showed excellent activity
against S. aureus (MIC = 159 𝜇g/mL), E. faecalis (MIC =
310 𝜇g/mL), and MRSA isolate (MIC = 630 𝜇g/mL).
As previously reported, the antimicrobial activity and
chemical composition of propolis are directly associated with
geographical location, biodiversity, bee species, and method
and time of harvest [28, 29].The high antibacterial activity of
propolis against Gram-positive bacteria, mainly strains of S.
aureus and Enterococcus sp., has been widely described [29–
31]. However, previous studies have shown awide variation in
MIC andMBCvalues [29, 31]. Up to now, there are few studies
on the antimicrobial activity of green and red propolis.
A study of Brazilian red propolis from state of Alagoas
reported that red propolis inhibited Streptococcus pyogenes
and various Gram-negative bacteria, such as P. aeruginosa
and E. coli with MIC values of 256 to 512𝜇g/mL [18].
Another study about Brazilian red propolis from the state of
Alagoas reported MICs values of 50 to 100 𝜇g/mL against S.
aureus ATCC 25923 and Streptococcus mutans UA159 [10].
Regarding green propolis types, a propolis sample collected
in Sa˜o Paulo state inhibited S. mutans at concentrations
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Figure 4: Compounds identified by GC-EIMS in the yellow propolis from Brazil.
of 400 𝜇g/mL [32]. If compared with previous studies, our
results showed that green propolis from Sa˜o Paulo andMinas
Gerais states was more effective at inhibiting Gram-positive
bacteria, with MIC values of 159 to 310 𝜇g/mL, whereas
Brazilian red propolis from Bahia state showed antibacte-
rial action similar to other studies published. The higher
antibacterial activity expressed by Brazilian green propolis
may be attributed to its different chemical composition and its
high concentration in flavonoids and aromatic acids such as
galangin, kaempferol, pinostrobin, and pinocembrin which
have shown high antibacterial effect, as reported by Grenho
et al. [33]. In addition, Scazzocchio et al. also reported
that some constituents such as flavonoids (kaempferide,
quercetin, galangin, and pinocembrin), caffeic, benzoic, and
4-hydroxy-3,5-diprenylcinnamic acids may probably act by
the inhibition of bacterial RNA polymerase but may also
act on the local microbial membrane or cell wall, causing
structural and functional damage, resulting in antimicrobial
action [30].
On the other hand, our data showed that the two
yellow propolis samples (EEP-Y MS and EMP-Y Cuba) were
not active against Gram-negative bacteria or Gram-positive
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Table 3: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) for different extracts of propolis.
Propolis
Bacteria, MIC and MBC/(𝜇g/mL)
Staphylococcus aureus Methicillin-resistantS. aureus (MRSA) Enterococcus faecalis
Pseudomonas
aeruginosa Escherichia coli
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
EEP-Y MS
>12,800 >12,800 >12,800 >12,800 >12,800 >12,800 6,400 >12,800 >12,800 >12,800
EMP-Y Cuba
>10,500 >10,500 >10,500 >10,500 5,020 10,500 5,020 6,400 >10,500 >10,500
EEP-B PR
>19,900 >19,900 >19,900 >19,900 860 >1,730 >13,900 >13,900 >13,900 >13,900
EEP-G MG 200 400 400 >400 400 800 6,450 12,900 6,450 12,900
EEP-G SP 159 315 630 >630 310 >630 10,110 20,220 10,110 20,220
EEP-R BA 390 780 780 >780 780 1,570 6,300 12,600 6,300 12,600
Chloramphenicol 50 >50 >50 >50 50 >50 — — — —
Gentamicin — — — — — — 4 10 10 10
DMSO
>19,900 >19,900 >19,900 >19,900 >19,900 >19,900 >19,900 >19,900 >19,900 >19,900
bacteria, with MIC values above 5020 𝜇g/mL. So far, there
are no previous reports on the chemical composition of
yellow propolis from Brazil and reports about their biological
activities are also scarce. Park et al. [5] reported that samples
of yellow propolis from Brazil were not active (or weakly
active) against S. aureus. Additionally, yellow propolis sam-
ples had low antioxidant and anti-inflammatory activities.
On the other hand, a previous report about yellow propolis
from Cuba showed that extracts were able to inhibit 50% of
S. aureus growth at low concentration, but no activity was
observed against E. coli [34]. These yellow propolis samples
from Cuba were abundant in triterpenoids and had a small
proportion of phenolics and flavonoids if compared with
green and red propolis.
4. Conclusions
The chemical composition of a yellow propolis from Mato
Grosso do Sul/Brazil was analysed and its in vitro biological
activity was assessed for the first time. This sample is rich in
triterpenes and presents a different qualitative profile from
other well-known types of Brazilian propolis. Yellow propolis
showed cytotoxic activity against human ovarian carcinoma
but was not active against Gram-negative or Gram-positive
bacteria. Our results indicate that the Brazilian brown, red,
and, to a lesser extent, yellow propolis inhibited, in a selective
way, the growth of tumour cells and therefore show poten-
tial for anticancer therapy. Brazilian green propolis showed
better antibacterial action, mainly against S. aureus and one
multidrug-resistant clinical isolate (MRSA).
The results of the present study expand the knowledge
about the chemical composition and biological activities
of different chemotypes of propolis from Brazil, showing
its variability and difficulty of standardization. Additionally,
there is a need to investigate the most appropriate pharma-
cological applications for the yellow type of propolis due to
its unique composition when compared to other types of
Brazilian propolis.
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